Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients
NCT04475120
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
92
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
liposomal lactoferrin
DRUG:
SOC therapy
Sponsor
University of Rome Tor Vergata